Literature DB >> 6527979

Pharmacokinetics of nicardipine following oral and intravenous administration in man.

D J Graham, R J Dow, D Freedman, E Mroszczak, T Ling.   

Abstract

The pharmacokinetics of nicardipine have been studied following oral and intravenous administration in man and the effects of food on nicardipine kinetics investigated. Following intravenous administration of nicardipine as an infusion plasma levels declined in a biphasic manner and plasma clearance values were of the same order as hepatic plasma flow. Following oral administration in the starved state nicardipine was rapidly absorbed but subject to presystemic elimination. Maximal plasma concentrations were achieved typically between 20 minutes and 2 hours after administration. The oral bioavailability of nicardipine determined by reference to a co-administered intravenous radiolabelled dose was found to be non-linearly related to dose. Bioavailability ranged from 15-45% approximately over the dose range 10-40 mg. Administration of nicardipine following a meal reduced the bioavailability of nicardipine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6527979

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  The effect of slow-release nicardipine on ambulatory and clinic blood pressure in mild hypertension.

Authors:  J P Cox; J Ryan; E O'Brien; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

2.  Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.

Authors:  A Danielsson; P Bjerle; B Ek; L Steen; O Suhr
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of felodipine. A summary.

Authors:  B Edgar; P Lundborg; C G Regårdh
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  Pharmacokinetics of calcium antagonists under development.

Authors:  D R Abernethy; J B Schwartz
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

5.  Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.

Authors:  D Maclean; E T Mitchell; E M Laing; F C Macdonald; K J Gough; R J Dow; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

6.  Nicardipine sustained release in hypertension.

Authors:  J Webster; J C Petrie; T A Jeffers; P Roy-Chaudhury; W Crichton; K Witte; M Jamieson; F C MacDonald; M Beard; R J Dow
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

Review 7.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

8.  Evaluation of a long acting formulation of nicardipine in hypertension by clinic and home recorded blood pressures and Doppler aortovelography.

Authors:  J Webster; K Witte; J Rawles; J C Petrie; T A Jeffers
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

9.  The metabolism and pharmacokinetics of nicardipine hydrochloride in man.

Authors:  D J Graham; R J Dow; D J Hall; O F Alexander; E J Mroszczak; D Freedman
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

10.  Intravenous nicardipine for treatment of postcoarctectomy hypertension in children.

Authors:  T A Nakagawa; S C Sartori; A Morris; D S Schneider
Journal:  Pediatr Cardiol       Date:  2003-10-13       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.